Safety, pharmacokinetics, and pharmacodynamics of the insulin-like growth factor type 1 receptor inhibitor figitumumab (CP-751,871) in combination with paclitaxel and carboplatin

Daniel D. Karp; Michael N. Pollak; Roger B. Cohen; Peter D. Eisenberg; Paul Haluska; Donghua Yin; Allan Lipton; Laurence Demers; Kim Leitzel; Mary L. Hixon; Leon W. Terstappen; Linda Garland; Luis G. Paz-Ares; Felipe Cardenal; Corey J. Langer; Antonio Gualberto

Journal of Thoracic Oncology (2009) - Comments
pubmed: 19745765 doi: 10.1097/jto.0b013e3181ba2f1d issn: 1556-0864 issn: 1556-1380

Daniel D. Karp, Michael N. Pollak, Roger B. Cohen, Peter D. Eisenberg, Paul Haluska, Donghua Yin, Allan Lipton, Laurence Demers, Kim Leitzel, Mary L. Hixon, Leon W. Terstappen, Linda Garland, Luis G. Paz-Ares, Felipe Cardenal, Corey J. Langer, Antonio Gualberto